Whalerock Point Partners Llc increased Amgen Inc (AMGN) stake by 22.51% reported in 2018Q1 SEC filing. Whalerock Point Partners Llc acquired 2,067 shares as Amgen Inc (AMGN)’s stock declined 5.44%. The Whalerock Point Partners Llc holds 11,248 shares with $1.92M value, up from 9,181 last quarter. Amgen Inc now has $120.04B valuation. The stock increased 1.58% or $2.8 during the last trading session, reaching $180.24. About 3.00 million shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 14.68% since May 31, 2017 and is uptrending. It has outperformed by 2.11% the S&P500.
Among 4 analysts covering Slate Retail REIT (TSE:SRT.UN), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Slate Retail REIT had 8 analyst reports since October 26, 2015 according to SRatingsIntel. As per Tuesday, November 17, the company rating was maintained by RBC Capital Markets. The rating was maintained by National Bank Canada on Monday, January 23 with “Outperform”. The company was maintained on Monday, October 26 by National Bank Canada. BMO Capital Markets maintained the shares of SRT.UN in report on Monday, February 27 with “Outperform” rating. The stock of Slate Retail REIT (TSE:SRT.UN) has “Outperform” rating given on Tuesday, June 7 by Raymond James. See Slate Retail REIT (TSE:SRT.UN) latest ratings:
Slate Retail REIT is an equity real estate investment trust launched and managed by Slate Properties Inc. The company has market cap of $583.43 million. The fund invests in the real estate markets of the United States. It has a 8.57 P/E ratio. It makes investments in grocery-anchored retail properties to create its portfolio.
The stock decreased 0.71% or $0.09 during the last trading session, reaching $12.66. About 11,475 shares traded. Slate Retail REIT (TSE:SRT.UN) has 0.00% since May 31, 2017 and is . It has underperformed by 12.57% the S&P500.
Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. has $220 highest and $160 lowest target. $193.36’s average target is 7.28% above currents $180.24 stock price. Amgen Inc. had 89 analyst reports since August 3, 2015 according to SRatingsIntel. Citigroup maintained it with “Neutral” rating and $172 target in Wednesday, September 28 report. The firm has “Buy” rating by Piper Jaffray given on Thursday, January 18. The stock has “Neutral” rating by Credit Suisse on Friday, February 2. Piper Jaffray maintained the shares of AMGN in report on Thursday, September 7 with “Buy” rating. Morgan Stanley maintained the stock with “Overweight” rating in Wednesday, April 25 report. The firm has “Buy” rating given on Tuesday, January 23 by Argus Research. The firm earned “Overweight” rating on Thursday, October 26 by Morgan Stanley. The rating was maintained by Oppenheimer with “Buy” on Monday, June 19. On Wednesday, January 24 the stock rating was maintained by JP Morgan with “Neutral”. On Tuesday, December 20 the stock rating was downgraded by Credit Suisse to “Neutral”.
Investors sentiment decreased to 0.88 in Q1 2018. Its down 0.34, from 1.22 in 2017Q4. It dropped, as 67 investors sold AMGN shares while 557 reduced holdings. 114 funds opened positions while 435 raised stakes. 502.72 million shares or 8.88% less from 551.71 million shares in 2017Q4 were reported. Aqr Management Ltd invested in 0.53% or 2.90 million shares. Mckinley Carter Wealth reported 2,508 shares. Cap Management Va reported 34,750 shares stake. Rech Global Invsts invested in 47.03 million shares. Taurus Asset Mngmt Ltd has invested 0.13% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Proshare Advsr Llc holds 659,496 shares or 0.73% of its portfolio. Excalibur Management Corp, Massachusetts-based fund reported 6,605 shares. Mcf Advsrs Ltd Com accumulated 0.04% or 1,199 shares. Personal Cap owns 159,871 shares or 0.42% of their US portfolio. Joel Isaacson And Comm Ltd Llc reported 3,821 shares. Jacobs Levy Equity Mgmt has invested 0.01% in Amgen Inc. (NASDAQ:AMGN). 1,962 were reported by Alta Management Ltd. Janney Ltd Liability Corporation stated it has 0.49% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Regentatlantic Cap Limited Liability Company owns 1.08% invested in Amgen Inc. (NASDAQ:AMGN) for 75,816 shares. Old Point Trust And Fincl Services N A accumulated 25,712 shares.
Since December 12, 2017, it had 0 insider buys, and 6 selling transactions for $1.64 million activity. 1,525 shares were sold by Harper Sean E, worth $269,666 on Tuesday, December 12.
More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: Nasdaq.com which released: “Biotech ETFs Are the Best Way to Play the Recovering Sector” on May 30, 2018, also 247Wallst.com with their article: “Amgen Wins Another FDA Approval” published on May 22, 2018, 247Wallst.com published: “Amgen’s Novel Migraine Treatment Gets Key Approval” on May 18, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Seekingalpha.com and their article: “Expanded label for Amgen’s Repatha approved in Europe” published on May 16, 2018 as well as Fool.com‘s news article titled: “Better Buy: Amgen Inc. vs. Biogen Inc.” with publication date: May 15, 2018.
The post Whalerock Point Partners Has Increased Amgen (AMGN) Stake By $351,390; 3 Analysts Are Bullish Slate Retail REIT (TSE:SRT.UN) Last Week appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/05/31/whalerock-point-partners-has-increased-amgen-amgn-stake-by-351390-3-analysts-are-bullish-slate-retail-reit-tsesrt-un-last-week/
No comments:
Post a Comment